• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The role of peri-operative chemotherapy for resectable colorectal liver metastasis: what does the evidence support?

作者信息

Pawlik Timothy M, Cosgrove David

机构信息

Department of Surgery, The Johns Hopkins University School of Medicine, Harvey 611, 600N Wolfe Street, Baltimore, MD 21287, USA.

出版信息

J Gastrointest Surg. 2011 Mar;15(3):410-5. doi: 10.1007/s11605-011-1423-z. Epub 2011 Jan 21.

DOI:10.1007/s11605-011-1423-z
PMID:21253876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3547619/
Abstract
摘要

相似文献

1
The role of peri-operative chemotherapy for resectable colorectal liver metastasis: what does the evidence support?围手术期化疗在可切除性结直肠癌肝转移中的作用：证据支持什么？
J Gastrointest Surg. 2011 Mar;15(3):410-5. doi: 10.1007/s11605-011-1423-z. Epub 2011 Jan 21.
2
What is the standard chemotherapy for colorectal cancer patients with resectable liver metastases?对于可切除肝转移的结直肠癌患者，标准化疗方案是什么？
Nat Clin Pract Oncol. 2009 Jan;6(1):14-6. doi: 10.1038/ncponc1274. Epub 2008 Nov 11.
3
Resectable colorectal liver metastases: optimal sequencing of chemotherapy.可切除的结直肠癌肝转移：化疗的最佳顺序
J Gastrointest Cancer. 2012 Sep;43(3):496-8. doi: 10.1007/s12029-011-9272-2.
4
Time to halt perioperative chemotherapy for resectable colorectal liver metastasis?是时候停止对可切除的结直肠癌肝转移患者进行围手术期化疗了吗？
Br J Surg. 2022 Feb 24;109(3):242-243. doi: 10.1093/bjs/znab425.
5
Peri-operative chemotherapy for patients with resectable colorectal hepatic metastasis: A meta-analysis.可切除性结直肠癌肝转移患者的围手术期化疗：一项荟萃分析。
Eur J Surg Oncol. 2015 Sep;41(9):1197-203. doi: 10.1016/j.ejso.2015.05.020. Epub 2015 Jun 11.
6
Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases.围手术期与术后化疗治疗可切除结直肠癌肝转移的有效性和成本效益。
Eur J Cancer. 2011 Oct;47(15):2291-8. doi: 10.1016/j.ejca.2011.05.014. Epub 2011 Jun 7.
7
Multicentre study of perioperative adjuvant chemotherapy for resectable colorectal liver metastases.多中心研究可切除结直肠癌肝转移的围手术期辅助化疗。
BJS Open. 2019 May 14;3(5):678-686. doi: 10.1002/bjs5.50174. eCollection 2019 Oct.
8
Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?新辅助化疗是否能揭示最初可切除的结直肠癌肝转移的疾病，从而使其无法进行手术治疗？
J Surg Oncol. 2012 Jan;105(1):55-9. doi: 10.1002/jso.22044. Epub 2011 Aug 12.
9
Improved first-line chemotherapy: a better chance for surgery?一线化疗的改进：手术机会是否增加？
Lancet Oncol. 2010 Jan;11(1):4-5. doi: 10.1016/S1470-2045(09)70345-6. Epub 2009 Nov 26.
10
[Combination of neoadjuvant chemotherapy, cryotherapy and surgery in the treatment of unresectable colorectal liver metastases. Long-term results].
Tumori. 2003 Jul-Aug;89(4 Suppl):107-8.

引用本文的文献

1
Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).转移性结直肠癌管理的临床实践指南：希腊医学肿瘤学家协会（HeSMO）共识声明
Ann Gastroenterol. 2016 Oct-Dec;29(4):390-416. doi: 10.20524/aog.2016.0050. Epub 2016 Jun 3.
2
Hepatic Resection for Disappearing Liver Metastasis: a Cost-Utility Analysis.肝切除治疗消失的肝转移瘤：成本效用分析
J Gastrointest Surg. 2015 Sep;19(9):1668-75. doi: 10.1007/s11605-015-2873-5. Epub 2015 Jun 16.
3
Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.新辅助化疗对可切除结直肠癌肝转移患者的疗效。
PLoS One. 2014 Jan 21;9(1):e86543. doi: 10.1371/journal.pone.0086543. eCollection 2014.
4
HER2-positive gastric cancer.人表皮生长因子受体 2 阳性胃癌。
Gastric Cancer. 2014 Jan;17(1):1-12. doi: 10.1007/s10120-013-0252-z. Epub 2013 Apr 7.
5
SSAT/AHPBA Joint Symposium: Today's approaches to colorectal cancer (CRC) liver metastases.SSAT/AHPBA联合研讨会：当今结直肠癌（CRC）肝转移的治疗方法
J Gastrointest Surg. 2011 Mar;15(3):404-5. doi: 10.1007/s11605-011-1425-x. Epub 2011 Feb 1.

本文引用的文献

1
Role of adjuvant therapy after resection of colorectal cancer liver metastases.结直肠癌肝转移术后辅助治疗的作用。
J Clin Oncol. 2010 May 1;28(13):2300-9. doi: 10.1200/JCO.2009.26.9340. Epub 2010 Apr 5.
2
Resection margin and recurrence-free survival after liver resection of colorectal metastases.结直肠转移瘤肝切除术后切缘与无复发生存。
Ann Surg Oncol. 2010 May;17(5):1324-9. doi: 10.1245/s10434-009-0770-4. Epub 2009 Oct 22.
3
Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis.重复治愈性意图肝切除术治疗复发性结直肠肝转移是安全有效的：来自国际多机构分析的结果。
J Gastrointest Surg. 2009 Dec;13(12):2141-51. doi: 10.1007/s11605-009-1050-0. Epub 2009 Oct 1.
4
Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients.结直肠癌肝转移根治性手术后的复发率及模式：一项对1669例患者的国际多机构分析
Ann Surg. 2009 Sep;250(3):440-8. doi: 10.1097/SLA.0b013e3181b4539b.
5
A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer.一项比较氟尿嘧啶/亚叶酸辅助治疗与 FOLFIRI 在结直肠癌肝转移完全切除术后患者中的随机 III 期研究。
Ann Oncol. 2009 Dec;20(12):1964-70. doi: 10.1093/annonc/mdp236. Epub 2009 Jun 30.
6
Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.在MOSAIC试验中，奥沙利铂、氟尿嘧啶和亚叶酸作为II期或III期结肠癌辅助治疗可提高总生存率。
J Clin Oncol. 2009 Jul 1;27(19):3109-16. doi: 10.1200/JCO.2008.20.6771. Epub 2009 May 18.
7
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study.贝伐珠单抗联合 FOLFOX、XELOX、FOLFIRI 和氟嘧啶类药物一线治疗转移性结直肠癌的安全性和有效性：BEAT 研究。
Ann Oncol. 2009 Nov;20(11):1842-7. doi: 10.1093/annonc/mdp233. Epub 2009 Apr 30.
8
Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.西妥昔单抗与化疗联合作为转移性结直肠癌的初始治疗方案
N Engl J Med. 2009 Apr 2;360(14):1408-17. doi: 10.1056/NEJMoa0805019.
9
Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.新辅助化疗的反应不能预测同时性结直肠肝转移患者的总生存期。
Ann Surg Oncol. 2009 Jul;16(7):1844-51. doi: 10.1245/s10434-009-0348-1. Epub 2009 Feb 18.
10
A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802).一项关于LV5FU2联合伊立替康与单纯LV5FU2用于辅助性高危结肠癌的III期随机试验（FNCLCC Accord02/FFCD9802）
Ann Oncol. 2009 Apr;20(4):674-80. doi: 10.1093/annonc/mdn680. Epub 2009 Jan 29.